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Liver grafts suﬀer from unavoidable injury due to ischemia and manipulation before implantation. Danger signals such as high-
mobility group box -1(HMGB1) and macrophage migration inhibitory factor (MIF) play a pivotal role in the immune response.
We characterized the kinetics of their release into the eﬄuent during cold/warm ischemia and additional manipulation-induced
mechanical damage. Furthermore, we evaluated the relationship between HMGB1/MIF release and ischemic/mechanical damage.
Liverenzymes andproteinintheeﬄuentincreasedwithincreasingischemiatime.HMGB1/MIF-releasecorrelatedwiththeextent
of hepatocellular injury. With increasing ischemia time and damage, HMGB1 was translocated from the nucleus to the cytoplasma
as indicated by weak nuclear and strong cytoplasmic staining. Enhancement of liver injury by mechanical damage was indicated
by an earlier HMGB1 translocation into the cytoplasm and earlier release of danger signals into the eﬄuent. Our results suggest
that determination of HMGB1 and MIF reﬂects the extent of ischemic injury. Furthermore, HMGB1and MIF are more sensitive
than liver enzymes to detect the additional mechanical damage inﬂicted on the organ graft during surgical manipulation.
1.Introduction
Theterm“transplantationinjury”describesthecombination
of all damaging events inﬂicted on the graft during the
transplantation procedure. The explantation injury is related
totheextentofmechanicalstressduringorganmanipulation
a n dt os o m ed e g r e ei su n a v o i d a b l ed u r i n gt h er e m o v a l
of the organ from the donor. Mechanical stress may vary
dependingontheindividualsurgeonaswellastheindividual
patient. Ischemia injury is induced by the combination of
ischemia and cold ischemia. Reperfusion injury and the
mainly mechanical implantation injury occur during organ
implantation.
Damage inﬂicted on cells leads to release of danger sig-
nals from dying cells or activated immune cells [1]. Danger
signals translate a damage into a molecular event, which
triggers the innate and adaptive immune response [1, 2].
Whatever inﬂicts damage on the body is detrimental.
This is the basic idea of the danger model of immunology
which was introduced by Matzinger in 1994 [3]. According
to the danger model in immunology, only antigen presenting
cells activated by cellular alarm signals from distressed cells
are able to initiate an immune response in an organism
[4, 5]. Alarm signals, such as heat shock protein 70 [6]a n d
high mobility group box protein 1 (HMGB1), are endoge-
nous danger signals [7, 8]. Danger signals form Damage-
Associated Molecular Patterns (DAMPs) [9]. DAMPs are
detected by pattern recognition receptors, orchestrating the
inﬂammatory and immunologic response [10, 11]. The role
of danger signals for the evaluation of liver graft damage2 Mediators of Inﬂammation
Table 1: Group distribution.
Damage type Strain Observation interval Observation time Eﬄuent Liver tissue
CI Lewis (n = 6) 1h 24h HMGB1; MIF Histology
M+CI Lewis (n = 6) 1h 24h AST; ALT HMGB1 IHC
WI Lewis (n = 6) 0,5h 6h
M+CI Lewis (n = 6) 0,5h 6h
CI BN (n = 6) 1h 24h
CI, cold ischemia; WI, warm ischemia; M, mechanical stress; HMGB1, high mobility group box-1; MIF, macrophage migration inhibitory factor; IHC,
immunohistochemistry; AST, aspartate aminotransferase; ALT, alanine transaminase.
remains unclear. Quantiﬁcation of danger signals, such as
HMGB1 and macrophage migration inhibitory factor (MIF)
prior to implantation of a graft, may be helpful in the
quantiﬁcation of preimplantation organ damage and could
serve as an indicator of organ quality, especially in marginal
grafts.
2.MaterialsandMethods
2.1. Experimental Design. The experiments were designed
to investigate the eﬀect of warm and cold ischemia as well
as mechanical damage on the intracellular location and the
release of damage markers—HMGB1 and MIF—into the
salinesolution.Warmischemicinjurywasinducedbystoring
the liver at 37◦C. Cold ischemic injury was induced by
storing the liver at 4◦C. Additional mechanical damage was
inﬂicted by placing a weight on the liver graft. Two rat strains
were used to test whether the release is strain independent
(Table 1).
2.2. Animals. Male inbred Lewis and BN rats (Central
Animal Facility of the University Hospital Essen), with
a weight at approximately 300–350g, were used in this
study. All animals were housed under standard animal care
conditions and had free access to water and rat chow ad
libitum. All procedures were carried out according to the
German Animal Welfare Legislation. Animal experiments
were approved by the Bezirksregierung D¨ usseldorf.
2.3.SurgicalProcedures. Surgicalprocedureswereperformed
under inhalation anesthesia with isoﬂurane (Sigma-Aldrich,
St. Louis, USA), (isoﬂurane concentration 3%, oxygen ﬂow
0,5l/min). After opening the abdomen with a transversal
incision, the liver was freed from its ligaments and ﬂushed
with cold saline solution.
In the mechanical stress groups, livers were subjected
to mechanical stress by placing a metal weight of 100g
repeatedly (10times) for 1min on the liver in situ prior to
explantation.
Infrahepatic vena cava and portal vein were cannulated
with 12G and 14G catheters, respectively. Cannulated livers
were placed in the incubator (37◦C) or refrigerator (4◦C).
At deﬁned intervals time (30min warm ischemia, 1h cold
ischemia), the livers were ﬂushed with saline (4◦C) at a
constant pressure of 10cm H2O through the portal vein,
and 1.5ml eﬄuent was collected from the infrahepatic
vena cava. Protease inhibitors (1ug/ml aprotinin, 1ug/ml
leupeptin, 1ug/ml pepstatin, 1mM PMSF 1mM NaF 1mM
Na3VO4) (Sigma-Aldrich, St. Louis, USA) were added to the
eﬄuent sample immediately after collection. Samples were
centrifuged thereafter to remove red blood cells.
2.4.LiverDamageAssessment. Toassesshepatocellularinjury
followingcoldorwarmischemia,aspartateaminotransferase
(AST) and alanine transaminase (ALT) were measured in
the eﬄuent using an Automated Chemical Analyzer (Bayer;
Leverkusen, Germany).
2.5. Histopathology. Liver tissue was ﬁxed in 4.5% buﬀered
formalin for at least 24h. Paraﬃn embedding was performed
using standard techniques. Sections (4μm) were cut and
stained with Hematoxylin-Eosin. Histological evaluation
focused on signs of cellular damage, such as vacuolization,
cell dissociation, cell swelling, and necrosis.
2.6. Gel Electrophoresis and Western Blotting. Eﬄuent sam-
ples were boiled for 10min in 1x loading buﬀer (0,06M
Tris-HCl, 5% SDS, 0.3% bromophenol blue, 10% glycerol,
and 0,1M Dithiothreitol) and were separated on 1,5mm
12% mini gels by SDS-PAGE. Proteins were transferred to
polyvinylidene diﬂuoride (PVDF) membranes (GE Health-
care, Buckinghamshire, UK) using a tank transfer unit
(Hoefer, San Francisco, USA). Membranes were blocked
using5%milksolution(5%nonfatmilkpowder,0.1%Tween
20 in PBS) for 1h at room temperature. Primary antibodies
(anti-HMGB1 polyclonal antibody, 1:1000, Abcam, Cam-
bridge, UK; anti-MIF polyclonal antibody, 1:3000, Abcam,
Cambridge, UK) were added to the membranes for 1h at
room temperature. Membranes were probed with secondary
goat antirabbit or donkey antigoat antibodies conjugated to
horseradish peroxidise (Abcam, Cambridge, UK). Detection
was performed employing the Lumi-Light Western Blot-
ting Substrate (Roche Applied Science, Mannheim, Ger-
many) and high sensitivity ﬁlms (GE Healthcare, Bucking-
hamshire, UK). Digitalization of ﬁlms was performed using
a scanner (Epson V750, Nagano, Japan). Quantiﬁcation of
band density was performed using Image J 1.40G (NIH,
Bethesda, USA). A standard curve covering a range from
0 to 2000ng/ml was generated using recombinant HMGB1Mediators of Inﬂammation 3
(Sigma-Aldrich, St. Louis, USA) to calculate the concentra-
tion of HMGB1 in the eﬄuent. In contrast, the result of the
quantiﬁcation for MIF was expressed in arbitrary units, since
no puriﬁed recombinant MIF was available.
2.7. Silver Staining. Following electrophoresis, acrylamide
gels were incubated in ﬁxing buﬀer for 1h (40% ethanol,
10% acetic acid). Subsequently, gels were submersed in a
5% ethanol-5% acetic acid solutions overnight. Gels were
then rinsed in distilled water for 5min and soaked in 10%
glutaraldehyde solution (Sigma-Aldrich, St. Louis, USA) for
30min at room temperature. Glutaraldehyde was removed
by washing with deionized water. Gels were incubated in
freshly prepared 0.1% ammoniacal silver nitrate solution
(Merck, Darmstadt, Germany) for 30min. After incubation,
gels were again brieﬂy washed in distilled water and then
incubated in developing solution buﬀer (0.01% formalde-
hyde and 0.01% citric acid) for 5 to 10min. The reaction was
stoppedbytheaddition of5%aceticacidsolutiontothegels.
2.8. Immunohistochemical Staining. For the immunohisto-
chemical detection of HMGB1, antigen retrieval was per-
formed in a water bath using citrate-EDTA buﬀer (10mM
Citric Acid, 2mM EDTA, 0.05% Tween 20, pH 6.2) for
20mins at 100◦C. Nonspeciﬁc protein binding was blocked
using 100ul serum-free blocking buﬀer (Dako, Glostrup,
Denmark). Slides were washed 3times with PBS. Sections
were incubated with diluted (1/500) polyclonal rabbit anti-
HMGB1 antibody (Abcam, Cambridge, UK) for 1 hour
at room temperature. The slides were rinsed with PBS,
and detection was performed using PowerVision goat-anti-
Rabbit-AP (ImmunoLogic, Duiven, Netherlands) employing
Fast-Red (Dako, Glostrup, Denmark) as substrate. Sections
were counterstained with Hematoxylin for 5mins. The
staining was documented using a digital camera (Olympus,
Tokyo, Japan) mounted on a microscope (Leica,Wetzlar,
Germany) at a magniﬁcation of 200x. Three pictures—one
from each lobular zone [12]—were selected randomly to
analyze HMGB1 staining. The percentage of hepatocytes
with only nuclear HMGB1 staining and only cytoplasmic
HMGB1 staining out of the total number of hepatocytes in
the three pictures taken (800–1000 cells) was calculated.
2.9. Statistical Analysis. Data are expressed as mean ± SD.
Diﬀerences between groups were evaluated for signiﬁcance
by one-way ANOVA analysis. Bivariate correlations were
tested with Spearman’s rank correlation. All tests were
performed using SigmaStat v3.5 (Systat-Software, Erkrath,
Germany). A P-value below.05 was considered statistically
signiﬁcant.
3. Results
3.1. Proteins in the Eﬄuent Increased with Ischemia Time and
Subsequent to Mechanical Stress. Damage to the graft leads
to the release of an array of proteins, such as liver enzymes,
danger signals, and others. Total protein in the eﬄuent
was taken as a parameter reﬂecting the release of proteins
into the ischemia solution and thereby indicating damage
to the graft. For a qualitative assessment of the change in
protein composition in the eﬄuent caused by explantation
and ischemia injury, silver staining was performed after
gel electrophoresis of the eﬄuent samples. Protein release
into the eﬄuent started after 1/0.5h of cold/warm ischemia
and increased with increasing ischemia time (Figures 1(a)
and 1(c)). Within the array of proteins released into the
eﬄuent, we identiﬁed one protein with a molecular weight
of about 28-kDa corresponding to the molecular weight
of HMGB1 and another protein with a molecular weight
of about 13-kDa corresponding to the molecular weight
of MIF. We conﬁrmed by immunoblotting that the bands
with the molecular weight corresponding to HMGB1 and
MIF showed a positive signal for the respective antibody.
Additional mechanical damage enhanced proteins release
(Figures 1(b) and 1(d)). Eﬄuent acquired from BN livers
showed a similar kinetic and staining pattern as eﬄuent
taken from Lewis livers (data not shown).
3.2.LiverInjuryIncreasedwithIschemiaTimeandMechanical
Stress. To determine the extent of hepatocellular injury in
relation to the explantation and ischemia period, AST and
ALT were measured in the eﬄuent. AST was undetectable
immediately after explantation and gradually increased with
time during warm or cold ischemia (Figures 2(a) and 2(b)).
Moderate release of liver enzymes (mean >10U/L) was
observed after 0.5h/2h of warm/cold ischemia. Substantial
release (mean >100U/L) occurred after 1h/13h hours of
warm/cold ischemia. AST release occurred earlier (0.5–
1.5hr/1–12hr warm/cold ischemia) and reached higher,
albeit not signiﬁcantly higher (P>. 05) levels when
grafts were subjected to additional mechanical stress during
explantation. Similar results were obtained for ALT and were
not aﬀected by the rat strain (data not shown).
Liver histology conﬁrmed that hepatic damage increased
with ischemia time. H&E staining showed normal hepatic
morphology at early time points (0h, 4h cold ischemia,
0h, 0,5h warm ischemia, resp.) (Figure 2(c)). Vacuolization
of cytoplasm and fragmentation of hepatocytcellular nuclei
as well as hepatocyte dissociation occurred after 1, 8h of
warm/cold ischemia, respectively, and became prominent
with increasing ischemia time. Progressive changes in cell
morphology,suchascellswelling,cytoplasmicvacuolization,
and nuclear fragmentation, were observed between 1hr and
6hr of warm ischemia, and similar results were obtained
when extending cold ischemia time from 12hr to 24hr
(Figure 2(d)).
3.3. Shift of HMGB1 Staining Pattern in Hepatocytes
upon Extended Cold/Warm Ischemia. Immunohistochemical
staining was performed to observe the intra-cellular distri-
butionofHMGB1inhepatocytesundergoingcoldandwarm
ischemia only (Figures 3(a1) and 3(a3)) as well as additional
mechanical injury (Figures 3(a2) and 3(a4)). The percentage
of hepatocytes with nuclear HMGB1 staining, cytoplasmic
HMGB1 staining, respectively, was calculated (Figure 3(b)).
Immunoreactivity to HMGB1 was found in the nuclei4 Mediators of Inﬂammation
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Figure 1: Release of proteins during ischemic storage of liver. Release of proteins into the eﬄuent collected at deﬁned intervals within after
24h cold ischemia or 6h warm ischemia was visualized by silver staining after electrophoresis. The concentration of total protein increased
substantially within the ﬁrst 30/60min of warm/cold ischemia. Arrows indicated the positions of HMGB1 and MIF. (a) Cold ischemia; (b)
mechanical stress plus cold ischemia; (c) warm ischemia, (d) mechanical stress plus warm ischemia.
of hepatocytes in normal livers (0hr). Single hepatocytes
(about 1%) showed cytoplasmic staining. When extending
warm/cold ischemia to 2/8hours, the proportion of cells
with strong cytoplasmic (>85% in warm/cold ischemia)
and weak or no nuclear staining increased substantially.
When extending the ischemic time further to 6/24hours
of warm/cold ischemia, nearly no nuclear staining (<5%
in warm/cold ischemia) and only weak or no cytoplasmic
staining were detected.
3.4. Mechanical Stress Associated with HMGB1 Translocation.
The percentage of hepatocytes with HMGB1 translocation
to the cytoplasma indicated by the weak nuclear and strong
cytoplasmic staining signiﬁcantly increased immediately
aftermechanicalstresstoapproximately10%.Incomparison
to livers without mechanical stress this diﬀerence was sta-
tistically signiﬁcant (P<. 001). Nonparenchymal liver cells
play an important role in the pathophysiology of warm/cold
ischemia. Activated Kupﬀer cells have been identiﬁed asMediators of Inﬂammation 5
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Figure 2: Liver damage during ischemic storage. Liver enzymes in the eﬄuent increased gradually in parallel to the length of warm/cold
ischemia time. Mean total liver enzymes values were higher, but not signiﬁcantly (P>. 05) ((a) and (b)). Liver injury was conﬁrmed by
liver histology (original magniﬁcation, 200x). Progressive changes in hepatocyte morphology such as cell dissociation (D), cytoplasmic
vacuolization (V), and nuclear pycnosis (P) did increase over ischemia time. (c) 0h cold ischemia (CI) liver tissue; (d) 24h CI liver tissue.
a critical source of HMGB1 and MIF. Kupﬀer cells and
sinusoidal endothelial cells presented with weak nuclear
staining and strong cytoplasmic staining immediately after
explantation (Figure 4). In contrast to the staining pattern
in hepatocytes, the staining pattern in vascular endothelial
cells and biliary epithelial cells remained constant. Vascular
endothelial cells were negative for HMGB1 at all time points.
Biliary epithelial cells were strongly HMGB1 positive during
the ischemia process throughout the observation period
(Figure 4).
3.5. HMGB1 and MIF Release into the Eﬄuent Is Dependent
ontheExtentofDamage. TodeterminewhetherHMGB1and
MIF were released and associated with hepatocellular injury,
Western blot analysis was performed on eﬄuent samples
obtained at deﬁned time points during the ischemia period.
HMGB1aswellasMIFreleasewasdetectedasearlyas10.8hr
(8hr–12hr) cold ischemia or 1.9hr (1.5hr–2.5hr) warm
ischemia and increased gradually (Figure 5(a)). Mechanical
damage induced by 10minutes of weight stress during
explantation followed by either warm or cold ischemia
drastically increased the release of HMGB1 and MIF into
the eﬄuent. Band density was assessed using Image J and
expressed as ng/ml (HMGB1) or arbitrary units (MIF)
(Figure 5(b)). In mechanical stress groups, HMGB1 was
already detected after 0.96hr (0.75–1.5hr) warm or 6.50hr6 Mediators of Inﬂammation
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Figure 3: Immunohistochemical analysis of HMGB1 expression in rat livers following cold/warm ischemia. Staining pattern changed
upon ischemia and mechanical stress (a). (a1) cold ischemia (CI), (a2) mechanical stress plus cold ischemia (M+CI), (a3) warm ischemia
(WI), (a4) mechanical stress plus warm ischemia (M+WI). Relative frequency of hepatocytes with nuclear and cytoplasmic staining (b). In
normal liver, only single hepatocytes showed cytoplasmic staining (<1%). The relative frequency increased with ischemia time and reached
a peak after 2h/8h (85%/95%) of warm/cold ischemia and decreased continuously thereafter. Mechanical stress inﬂicted on the liver during
explantation increased HMGB1 translocation (P<. 05 versus without mechanical stress groups). Data shown are representative of all tissue
samples analyzed at a magniﬁcation of 200x. ∗P<. 05.
(5–8hr) cold ischemia, respectively, which was signiﬁcantly
earlier than in groups subjected to ischemic injury only (P =
.0027, P = .0020, resp.).
At these time points (0.75–1.5h/5–11h in warm/cold
ischemic ischemia), the relative concentration of HMGB1
in the eﬄuent was also signiﬁcantly higher compared with
groups subjected to ischemia only (P<. 05). MIF release,
also detected by Western blot, followed a similar kinetic as
HMGB1 release and was also released signiﬁcantly higher
upon mechanical stress compared to ischemia only. In
contrast, additional mechanical stress did not lead to a
signiﬁcantly higher release of liver enzymes into the eﬄuent
compared with groups subjected to ischemia only (P>. 05).
A similar release pattern of HMGB1 was also observed
in explanted BN livers, which were subjected to 24h cold
ischemia. These data indicated that HMGB1 was released inMediators of Inﬂammation 7
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Figure 4: HMGB1-staining patterns in non-parenchymal cells.
Kupﬀer cells (KCs) presented with weak nuclear staining but strong
cytoplasmic staining. Vascular endothelial cells (ECs) were negative
for HMGB1, and biliary epithelial cells (BC) were strongly HMGB1
positive during ischemia process (200x).
a strain-independent manner during ischemia of liver (data
not shown).
3.6. AST and ALT as well as HMGB1 and MIF Show a Similar
Release Pattern. We determined the correlation between the
release of hepatic enzymes and the length of the ischemic
time. To determine this correlation, data from cold and
warm ischemia without additional mechanical damage were
used. AST positively correlated with cold or warm ischemic
time (r = .9368, P<. 0001 and r = .7810, P<. 0001,
resp., (Figures 6(a) and 6(b)). Evaluation of the correlation
between the release of danger signals and ischemic time
revealed a moderate correlation of HMGB1 and MIF release
into the eﬄuent with the length of cold (r = .8670, P<. 0001
and r = .8630, P<. 0001, resp.) and warm (r = .8740,
P<. 0001 and r = .8194, P<. 0001, resp., Figures 6(c) and
6(d)) ischemic time.
Calculating the correlation between HMGB1 release and
liver enzymes, respectively, eﬄuent HMGB1 moderately
correlated with AST in the eﬄuent (r = .6657, P<
.0001) (Figure 6(e)). MIF, and AST release also moderately
correlated (r = .4901, P<. 0001) (Figure 6(f)). Similar
results were obtained for ALT (data not shown). HMGB1
release from BN livers was moderately correlated to the
release of liver enzymes (data not shown).
4. Discussion
In a previous rat liver transplantation study, we demon-
stratedthatallratsdiedwithin48hafterlivertransplantation
when the cold ischemia time in saline was prolonged to
10h. Nearly 50% died once a cold ischemia time of 9h was
employed. Cold ischemia of the graft for a period under
9h was associated with 100% survival (paper submitted for
publication). A marked increase in AST, ALT as well as
HMGB1, MIF was observed after 9–10h of ischemia, the
same length of graft ischemia time that led to decreased
animal survival.
HMGB1 release following ischemic injury of the liver
was observed in clinical as well as in experimental studies.
HMGB1 has been implicated in ischemia/reperfusion injury
of the liver [13], kidney [14], heart [15], and brain [16].
Ilmakunnas et al. were the ﬁrst to evaluate the danger
signal HMGB1 as a marker for hepatocellular injury. In
their study, HMGB1 was undetectable in the systemic
circulation before human liver transplantation, and the peak
value appeared 10minutes after portal vein declamping and
showed moderate correlation with AST. They concluded that
HMGB1 released from a human liver graft could be used
as a marker of liver injury [17]. Tsung observed in a mouse
ischemia/reperfusionmodelthatHMGB1proteinexpression
in the liver increased with time up to 24h following
60min of warm ischemia of the liver [18], suggesting an
active production of HMGB1 in addition to a cell damage-
associated release.
Extracellular HMGB1 is a mediator of inﬂammation
[1, 19–21]. Before HMGB1 is released from cells, HMGB1
is translocated from the nucleus into the cytoplasm. Translo-
cation is associated with acetylation [22], phosphorylation
[23], and methylation [24] of HMGB1. Once released,
HMGB1 exerts biologic eﬀects through its receptors. Sev-
eral receptors have been implicated in HMGB1 signalling,
including the receptor for advanced glycation end product
(RAGE) and Toll-like family receptors, such as Toll-like
receptor 4(TLR4); Toll-like receptor 2(TLR2), and Toll-like
receptor 9(TLR9) [25, 26]. Signalling of these receptors
induces production and release of inﬂammatory cytokines
by immune cells. In our study, we found that HMGB1 was
released from liver cells after prolonged warm/cold ischemia.
HMGB1 release to the extracellular space may be governed
by two diﬀerent mechanisms [27]. One mechanism is an
active secretion process. This mechanism is employed by
immune cells; HMGB1 can be actively secreted by activated
macrophages, NK cells, and mature myeloid DCs [22, 28,
29]. A second mechanism is a passive release process.
HMGB1 is released when cells undergo necrosis [30–35].
In this study, HMGB1 translocated from the hepatocellular
nucleus to the cytoplasma and also to the extracellular space.
The kinetic of the HMGB1 translocation was in parallel to
the overall injury of the organ graft as demonstrated by a
release of liver damage markers (AST and ALT) as well as
an increase in proteins in the eﬄuent as demonstrated by
a silver stain in a polyacrylamide gel. Translocation to the
cytoplasma was seen prior to the release into the eﬄuent.
Loss of cytoplasmic HMGB1 paralleled the detection in
the eﬄuent; supporting the hypothesis HMGB1 was indeed
released by damaged hepatocytes.
MIF release following ischemic injury of the liver was
observed in clinical as well as in experimental studies. MIF is
another well-known cytokine that is released from immune
cells and plays an important role in inﬂammatory diseases
[36–39]. It has been reported that MIF is constitutively8 Mediators of Inﬂammation
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Figure 5:Releaseofdangersignalsduringischemicstorageofliver.Eﬄuentobtainedafterﬂushingtheliverinhalf-hourlyorhourlyintervals
for either 24 or 6h was assessed for HMGB1 and MIF using Western blot (a). Release of both danger signals, HMGB1 and MIF, was detected
by Western blot. (a1) Cold ischemia; (a2) mechanical stress plus cold ischemia; (a3) warm ischemia; (a4) mechanical stress plus warm
ischemia. Band density was assessed using Image J program and expressed as ng/ml (HMBG1) or arbitrary units (MIF) (b). Danger signals
were released signiﬁcantly earlier in both groups subjected to mechanical stress compared with ischemia only group (P = .0027; P = .002,
resp.). At earlier time points (0.75–1.5h/5–11h in warm/cold ischemic ischemia), the relative concentration of HMGB1 and MIF in the
eﬄuent was also signiﬁcantly higher compared with groups subjected to ischemia only (∗P<. 05).Mediators of Inﬂammation 9
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Figure 6: Correlation of Eﬄuent HMGB1 and MIF with liver enzymes (AST) and ischemic time. Eﬄuent AST positively correlated with
cold or warm ischemic time ((a) and (b)), respectively, (P<. 0001). For HMGB1, the values represent the density of band using Image J
program ((c) and (d)), or the values represent the concentration quantiﬁed by recombinant standard (e). For MIF, the values represent the
density of band using Image J program. Eﬄuent HMGB1 and MIF levels correlated moderately with ischemic time ((c) and (d); P<. 0001)
and eﬄuent AST ((e) and (f); P<. 0001).
expressed in the hepatocytes [40]. In contrast to most
cytokines, MIF is stored in intracellular pools and secreted
immediately by nonconventional protein-secretion pathway
before de novo protein synthesis [41]. MIF was released
by macrophages after stimulation with Lipopolysaccharide
(LPS), Tumor necrosis factor-alpha (TNF-α), or Interferon-
gamma (IFN-γ)[ 37, 41]. MIF level was elevated in tissue
and serum in a mouse sepsis model [37] and also increased
in the serum of patients with septic shock [42]. It has
been reported that plasma MIF is signiﬁcantly elevated in
patients after liver resection, indicating that MIF has a
role in mediation of systemic inﬂammatory response after
surgery injury [43]. A rapidly growing body of evidence
supports that MIF is involved in the inﬂammatory cascade10 Mediators of Inﬂammation
andischemia/reperfusioninjury[44,45].Itwasreportedthat
liver I/R injury causes the expression of MIF [46], and anti-
MIF antibody attenuates hepatic injury in a mice endotoxin-
inducedfatalhepaticfailuremodel.Inthisstudy,theamount
ofMIFwassigniﬁcantlyincreasedafterprolongedwarm/cold
ischemia. Liver non-parenchymal cells, including Kupﬀer
cells and the sinusoidal endothelial cells, are sensitive to
ischemia. MIF mRNA was increased immediately in livers
during cold ischemia (data not included). It appears likely
that MIF was mainly actively released from liver non-
parenchymal cells.
HMGB1 release subsequent to mechanical trauma was
described in several clinical and experimental papers. Peltz
et al. reported that plasma HMGB1 increased signiﬁcantly
within1hrinpatientswithbluntorpenetratingtraumaanda
severityscoregreaterthanorequalto15.Peaklevelsoccurred
from 2 to 6hr after injury [47]. Using an experimental
model, Levy et al. observed that HMGB1 was elevated in
serum1hafterperipheralinjuryconsistingofabonefracture
in mice [48].
MIFcouldbealsoanimportantcytokineininjurycaused
by trauma. Jeschke et al. reported that the amount of MIF
in serum was signiﬁcantly increased in rat thermal trauma
models [49]. MIF gene expression and protein levels were
signiﬁcantly increased in murine and canine acute lung
injury models. Serum level of MIF was also signiﬁcantly
elevated in patients with sepsis induced acute lung injury
[50]. Plasma MIF increased signiﬁcantly in pediatric patients
undergoing surgery for congenital heart disease [51]. We
found that additional mechanical stress further enhanced
their release, both in the cold as well as the warm ischemia
group.
HMGB1 as well as MIF were released at earlier time
points after liver explantation and graft ischemia compared
to liver enzymes. During this interval, a statistically signiﬁ-
cant increase in AST and ALT was not observed.
5. Conclusion
AST and ALT as well as HMGB1 and MIF levels in the
eﬄuent can be used to assess the extent of damage from
warm and cold ischemia in the liver graft. Notably, at early
timepoints,additionalmechanicalstressledtoasigniﬁcantly
higher release of HMGB1 and MIF but not of liver enzymes
into the eﬄuent than ischemia only. In this situation, a
signiﬁcantly increased nuclear cytoplasmic translocation of
HMGB1 was visualized in hepatocytes by immunohisto-
chemistry.OurresultssuggestthatdeterminationofHMGB1
and MIF reﬂects the extent of ischemic injury. In case of
additional mechanical damage, as inﬂicted on the organ
during surgical manipulation, additional determination of
danger signals seemed to be superior to determination of
liver enzymes only, as damage was indicated earlier.
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